Allspring Global Investments Holdings LLC Buys 52,696 Shares of Perrigo Company plc (NYSE:PRGO)

Allspring Global Investments Holdings LLC lifted its stake in shares of Perrigo Company plc (NYSE:PRGO) by 5.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,092,398 shares of the company’s stock after purchasing an additional 52,696 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Perrigo were worth $28,402,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Franklin Resources Inc. purchased a new stake in shares of Perrigo in the third quarter worth about $3,717,000. Foundry Partners LLC purchased a new stake in Perrigo in the 3rd quarter worth approximately $7,111,000. Barclays PLC boosted its holdings in Perrigo by 44.8% in the 3rd quarter. Barclays PLC now owns 120,502 shares of the company’s stock valued at $3,160,000 after purchasing an additional 37,268 shares during the period. JPMorgan Chase & Co. grew its position in shares of Perrigo by 65.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company’s stock valued at $14,190,000 after purchasing an additional 213,221 shares in the last quarter. Finally, Citigroup Inc. raised its position in shares of Perrigo by 94.1% in the third quarter. Citigroup Inc. now owns 151,520 shares of the company’s stock worth $3,974,000 after buying an additional 73,457 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Insiders Place Their Bets

In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the transaction, the director now owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. This trade represents a 76.49 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

PRGO has been the subject of several recent analyst reports. Argus cut Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, StockNews.com upgraded shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Monday, February 10th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $35.00.

Perrigo Stock Performance

NYSE:PRGO opened at $24.48 on Friday. The company has a market capitalization of $3.34 billion, a price-to-earnings ratio of -20.93 and a beta of 0.54. The business has a 50 day moving average of $25.25 and a 200 day moving average of $26.37. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.